Cancer stem cells in glioblastoma--molecular signaling and therapeutic targeting. - Wikidata - awgldk - TriplyDB

Cancer stem cells in glioblastoma--molecular signaling and therapeutic targeting.

Cancer stem cells in glioblastoma--molecular signaling and therapeutic targeting.

http://www.wikidata.org/entity/Q37825821

about

Glioblastoma Stem Cells as a New Therapeutic Target for Glioblastoma Oxygen levels and the regulation of cell adhesion in the nervous system: a control point for morphogenesis in development, disease and evolution?The three-layer concentric model of glioblastoma: cancer stem cells, microenvironmental regulation, and therapeutic implications MicroRNA Regulation of Brain Tumour Initiating Cells in Central Nervous System Tumours The function of miRNA in hepatic cancer stem cell Brain tumor stem cells: Molecular characteristics and their impact on therapy Ubiquitination and deubiquitination of REST and its roles in cancers Contemporary murine models in preclinical astrocytoma drug development miR-9: a key factor of the physiopathological regulation of the neural progenitor state Phosphoproteome of human glioblastoma initiating cells reveals novel signaling regulators encoded by the transcriptome A novel berbamine derivative inhibits cell viability and induces apoptosis in cancer stem-like cells of human glioblastoma, via up-regulation of miRNA-4284 and JNK/AP-1 signaling Selective calcium sensitivity in immature glioma cancer stem cells Antibody discovery ex vivo accelerated by the LacO/LacI regulatory network Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition.Oncogenic effects of miR-10b in glioblastoma stem cells CSNK1A1 and Gli2 as Novel Targets Identified Through an Integrative Analysis of Gene Expression Data, Protein-Protein Interaction and Pathways Networks in Glioblastoma Tumors: Can These Two Be Antagonistic Proteins?Glioblastoma biomarkers from bench to bedside: advances and challenges.Casein Kinase 2: a novel player in glioblastoma therapy and cancer stem cells.The inhibition of KCa3.1 channels activity reduces cell motility in glioblastoma derived cancer stem cells.Endothelial cells promote stem-like phenotype of glioma cells through activating the Hedgehog pathway.Modulation of PPIX synthesis and accumulation in various normal and glioma cell lines by modification of the cellular signaling and temperature.Gene therapy for malignant glioma.Drug resistance in glioblastoma: a mini review Protein tyrosine phosphatase mu regulates glioblastoma cell growth and survival in vivo.Sendai virus-based liposomes enable targeted cytosolic delivery of nanoparticles in brain tumor-derived cells.Glioma Cells in the Tumor Periphery Have a Stem Cell Phenotype Metallofullerene-nanoplatform-delivered interstitial brachytherapy improved survival in a murine model of glioblastoma multiforme Osteopontin increases heme oxygenase-1 expression and subsequently induces cell migration and invasion in glioma cells.uPAR and cathepsin B knockdown inhibits radiation-induced PKC integrated integrin signaling to the cytoskeleton of glioma-initiating cells.Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence.Role of MicroRNAs in Malignant Glioma Glioma stem cells and immunotherapy for the treatment of malignant gliomas.Strategies for isolating and enriching cancer stem cells: well begun is half done Disrupting the CXCL12/CXCR4 axis disturbs the characteristics of glioblastoma stem-like cells of rat RG2 glioblastoma.Migrating glioma cells express stem cell markers and give rise to new tumors upon xenografting.BIX01294, an inhibitor of histone methyltransferase, induces autophagy-dependent differentiation of glioma stem-like cells.Fibulin-3 promotes glioma growth and resistance through a novel paracrine regulation of Notch signaling.Targeting Protein Kinase CK2: Evaluating CX-4945 Potential for GL261 Glioblastoma Therapy in Immunocompetent Mice.Role of microRNAs in gliomagenesis: targeting miRNAs in glioblastoma multiforme therapy.

P2860

Q26776219-F77E24AD-D375-4050-9A4F-86F9EFDF9BF1 Q26824421-FC497B26-E79D-4606-9351-5B47307F8641 Q26829663-BB6AEA78-04AB-4AC2-8E8B-C4FAD32C5A68 Q27002604-46D1D79E-D3D8-43F8-8816-6329FAD87F10 Q27002614-7CC76EB5-9D09-41FD-AE07-5206AD280245 Q27003138-4E4AB791-22E6-46A5-88E3-FC2A80D71F94 Q27026268-654D7CF2-EED3-457F-9E5C-AF6C02F10C60 Q27026937-9D9BB6D9-25B9-452C-A043-6ECE69E7D85B Q27027980-34707210-67C2-4110-86BC-48E4CA72B217 Q28482324-10728317-E782-4386-B365-738CC846E72C Q28537845-B67B6205-365A-4CF0-8EA3-291FFAD3415C Q28542816-EB9A3046-9BCF-455F-BB14-315FC9158249 Q28730290-8815D6F2-F243-48EC-9FC8-CED9960081CF Q30275189-BC817D7D-DEDF-4E8A-8310-91784B036CC5 Q30414066-08C75CA9-A218-4929-BD8F-AE9DC1E85184 Q30867941-4A1A7465-BEAE-486D-A825-C856AD6836C9 Q34103890-BB8836B3-C9AD-43AE-B274-CED2E702BB36 Q34247901-C4C1E932-F02D-4D64-9188-C3D522D34FA7 Q34460616-ACC44F7E-2324-4A27-98DF-1D4419B35B57 Q34658803-416DB593-7347-4316-8D96-78552489A8B7 Q34987635-6C5D3FDA-C4C4-4E62-B558-98F47C56B6FB Q35673628-9D6A5797-5022-49FD-9495-06F2E0D00D41 Q35899534-4B37FECB-B766-474E-B7EC-060A7084FA56 Q35914525-EC0917C1-8905-4497-BA12-1B88802B93B1 Q35959467-DF2D0C0D-B3B0-46A6-A2C7-77868B02AFB7 Q36015831-9076C164-0D07-449B-87A1-E3C98F557AF3 Q36251215-55773E03-AE64-4E98-878D-D4EE2E7FA0AB Q36344784-DCE9B862-7B29-4E4A-8073-4E36C220D512 Q36352945-D2F092E8-AF95-4060-B15E-105F2DB88CD9 Q36545726-604EE549-9F37-4364-816D-AA5E7605E845 Q36795940-A91CDA21-13AC-479D-9E0B-25F78ECBC062 Q36797902-1A3A8682-4141-4F25-96EB-81732C586990 Q36898699-200C90DA-88F8-447B-B0A1-3FA25A09A7EF Q37061915-E5C43991-7FE7-4DD0-AA63-CFD935594D3A Q37153084-2500A4FB-462D-4FE9-9F24-C14C22041DA4 Q37348475-E97610A4-F93A-4A73-A99E-532C6926DC76 Q37487279-D6F980D9-34BA-4A71-A176-12B49518B4A4 Q37494827-968FA50D-4579-4C4E-89F7-98A90460887A Q37731326-2FE9719F-3F25-4AC7-93C1-2461AC9B0486 Q38027227-A6E7B8A5-5CFD-483C-9B81-521B9E9331D4

P2860

Cancer stem cells in glioblastoma--molecular signaling and therapeutic targeting.

http://www.wikidata.org/entity/Q37825821

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 July 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cancer stem cells in glioblastoma--molecular signaling and therapeutic targeting.

@en

Cancer stem cells in glioblastoma--molecular signaling and therapeutic targeting.

@nl

type

label

Cancer stem cells in glioblastoma--molecular signaling and therapeutic targeting.

@en

Cancer stem cells in glioblastoma--molecular signaling and therapeutic targeting.

@nl

prefLabel

Cancer stem cells in glioblastoma--molecular signaling and therapeutic targeting.

@en

Cancer stem cells in glioblastoma--molecular signaling and therapeutic targeting.

@nl

P1433

Q37825821-24DBDC70-C2B7-47BB-BB21-933ABFDB4AF3

P1476

Q37825821-C944A5B1-D5CA-4537-A42C-1AAF9EA5B5F9

P2093

Q37825821-1F64EFF1-4E09-440C-8EC5-25BA79852B29

Q37825821-2619DD08-2786-4BC3-819B-77BE76E74E15

Q37825821-4AE72C1E-2356-46EF-AAC7-3E7035075F11

Q37825821-4F5ACA67-BF04-430D-AA02-4761A909366D

Q37825821-AD868CB8-3781-40C8-8282-8B4F43AEFFB9

P2860

Q37825821-00AF8E34-8AFB-455F-B179-F3FD7EA6B40E

Q37825821-01EEB73F-91A6-4F10-A103-D730AD07AB85

Q37825821-0303F3EC-DF26-4D08-B83F-A10FCFB4B5D4

Q37825821-04DDAA41-5627-47B4-AA3E-EB36F9377B2D

Q37825821-04FE0630-4771-45E8-A724-9C6421A60707

Q37825821-09209534-57A5-44CA-8520-0F0567D8C0B8

Q37825821-09DE7BBE-39C4-4629-95F9-519CFB3E91C8

Q37825821-0C126ACF-0EC5-4844-916D-B53B2D6DE266

Q37825821-101B7986-0EDE-47E8-AFCB-7C2765CCA64B

Q37825821-1216A6C2-F2BD-4A18-BAEF-068F51DE58B6

P2888

Q37825821-FFAB9065-264C-48D6-B541-8CBD194E287E

P304

Q37825821-1F69BE17-C97B-4D35-8AA2-D0E4BA8530EC

P31

Q37825821-D5B705C8-C9EC-4BA7-8540-03B96111F2D0

Q37825821-fd6f93c1-f876-4ba2-9dc9-71c1773f50c7

P356

Q37825821-BC6CB7CE-FC63-4C12-ACD8-B24616EDE211

P433

Q37825821-40419443-F9E1-4C32-8F01-201971DC2408

P478

Q37825821-2F98717B-83F0-4549-AD6C-330CEB09A3B2

P577

Q37825821-D06CAD3F-9727-469E-893D-AA88FEC3DC51

P5875

Q37825821-5118ED42-2DD1-4166-95B3-841986C940FA

P698

Q37825821-6BCAC711-359C-4FA5-AD2E-7013F625762F

P932

Q37825821-1795C41B-E7C0-4432-9411-DA2240F9962B

P356

S13238-010-0078-Y

P1433

P1476

Cancer stem cells in glioblastoma--molecular signaling and therapeutic targeting.

@en

P2093

Lin Cheng

http://www.w3.org/2001/XMLSchema#string

Olga A Guryanova

http://www.w3.org/2001/XMLSchema#string

Qiulian Wu

http://www.w3.org/2001/XMLSchema#string

Shideng Bao

http://www.w3.org/2001/XMLSchema#string

Zhi Huang

http://www.w3.org/2001/XMLSchema#string

P2860

miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells

The Hallmarks of Cancer

Regulation of self-renewal and pluripotency by Sox2 in human embryonic stem cells

Sox11 prevents tumorigenesis of glioma-initiating cells by inducing neuronal differentiation

A distinct "side population" of cells with high drug efflux capacity in human tumor cells

Cancerous stem cells can arise from pediatric brain tumors

Identification of cells initiating human melanomas

The epithelial-mesenchymal transition generates cells with properties of stem cells

Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation

The basics of epithelial-mesenchymal transition

P2888

s13238-010-0078-y

P304

638-655

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13238-010-0078-Y

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49726726

http://www.w3.org/2001/XMLSchema#string

P698

21203936

http://www.w3.org/2001/XMLSchema#string

P932

4875273

http://www.w3.org/2001/XMLSchema#string